Thousand Oaks, CA, United States of America

Dimitry Michael Danilenko


Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 116(Granted Patents)


Location History:

  • Camarillo, CA (US) (1999)
  • Thousand Oaks, CA (US) (2008 - 2009)

Company Filing History:


Years Active: 1999-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Dimitry Michael Danilenko

Introduction: Dimitry Michael Danilenko is a prominent inventor based in Thousand Oaks, California, known for his groundbreaking contributions in the field of biotechnology. With a total of four patents to his name, Danilenko has made significant strides in the development of polypeptides and their applications in medical treatments.

Latest Patents: Danilenko’s latest inventions include two notable patents. The first patent concerns "Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof," specifically focusing on the novel β10 polypeptides and their heterodimeric forms, like α2/β10. This invention encompasses vectors, host cells, selective binding agents, and detailed methods to produce β10 polypeptides, which have potential applications in treating various diseases.

The second patent titled "Fibroblast growth factor-like polypeptides" showcases Danilenko's innovation in creating new Fibroblast Growth Factor-like (FGF-like) polypeptides and their corresponding nucleic acid molecules. This invention also includes vectors, host cells, antibodies, and methods for producing FGF-like polypeptides, which can significantly aid in diagnosing and treating diseases associated with these proteins.

Career Highlights: Danilenko is currently associated with Amgen Inc., a leading biotechnology company, where he applies his expertise in genetic research and polypeptide development. His work contributes to advancing therapeutic solutions that address various health issues, showcasing his dedication to enhancing human health through innovative science.

Collaborations: Throughout his career, Danilenko has collaborated with esteemed colleagues such as Christopher J R Paszty and Jin Cao. These partnerships have fostered a collaborative environment that encourages innovation and the pursuit of new medical technologies, further enhancing the efficacy of his inventions.

Conclusion: Dimitry Michael Danilenko stands out as a remarkable inventor whose contributions to biotechnology are shaping the future of medicine. His patents not only reflect his innovative mindset but also promise to improve treatments for a range of diseases, affirming his role as a vital contributor to the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…